Affinity DataKi: 0.0530nMAssay Description:Displacement of [3H]PF-06883365 from FAP-tagged human GLP-1R expressed in CHO cells assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.0920nMAssay Description:Displacement of [125I]GLP-1 from FAP-tagged human GLP-1R expressed in CHO cells assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.340nMAssay Description:In vitro binding affinity of the compound was determined against human type 1a growth hormone secretagogue receptor (hGHS-R1a), using [125I]-ghrelin ...More data for this Ligand-Target Pair
Affinity DataKi: 0.450nMAssay Description:In vitro binding affinity of the compound was determined against human type 1a growth hormone secretagogue receptor (hGHS-R1a), using [125I]-ghrelin ...More data for this Ligand-Target Pair
Affinity DataKi: 4.40nMAssay Description:Displacement of [125I]GLP-1 from FAP-tagged human GLP-1R expressed in CHO cells assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 5nMAssay Description:In vitro binding affinity of the compound was determined against human type 1a growth hormone secretagogue receptor (hGHS-R1a), using [125I]-ghrelin ...More data for this Ligand-Target Pair
Affinity DataKi: 6.30nMAssay Description:Displacement of [3H]PF-06883365 from FAP-tagged human GLP-1R expressed in CHO cells assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 7nMAssay Description:In vitro binding affinity of the compound was determined against human type 1a growth hormone secretagogue receptor (hGHS-R1a), using [125I]-ghrelin ...More data for this Ligand-Target Pair
Affinity DataKi: 10nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 10nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 18nMAssay Description:In vitro binding affinity of the compound was determined against human type 1a growth hormone secretagogue receptor (hGHS-R1a), using [125I]-ghrelin ...More data for this Ligand-Target Pair
Affinity DataKi: 21nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 30nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 37nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 37nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 49nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 50nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 51nMAssay Description:Displacement of [3H]PF-06883365 from FAP-tagged human GLP-1R expressed in CHO cells assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 80nMAssay Description:Displacement of [3H]PF-06883365 from FAP-tagged human GLP-1R expressed in CHO cells assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 97nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 100nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 100nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 120nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 120nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 130nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 140nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 150nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 170nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 200nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 210nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 270nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 360nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 360nMAssay Description:Displacement of [125I]GLP-1 from FAP-tagged human GLP-1R expressed in CHO cells assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 400nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 400nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 500nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 1.55E+3nMAssay Description:Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
TargetMicrosomal triglyceride transfer protein large subunit(Homo sapiens (Human))
Pfizer Inc
Curated by ChEMBL
Pfizer Inc
Curated by ChEMBL
Affinity DataIC50: 0nMAssay Description:Inhibition of MTP in human HepG2 cells assessed as unbound drug level causing inhibition of apoB secretion after 40 hrs by ELISAMore data for this Ligand-Target Pair
TargetMicrosomal triglyceride transfer protein large subunit(Homo sapiens (Human))
Pfizer Inc
Curated by ChEMBL
Pfizer Inc
Curated by ChEMBL
Affinity DataIC50: 0.00100nMAssay Description:Inhibition of MTP in human HepG2 cells assessed as unbound drug level causing inhibition of apoB secretion after 40 hrs by ELISAMore data for this Ligand-Target Pair
TargetMicrosomal triglyceride transfer protein large subunit(Homo sapiens (Human))
Pfizer Inc
Curated by ChEMBL
Pfizer Inc
Curated by ChEMBL
Affinity DataIC50: 0.00100nMAssay Description:Inhibition of MTP in human HepG2 cells assessed as unbound drug level causing inhibition of apoB secretion after 40 hrs by ELISAMore data for this Ligand-Target Pair
TargetMicrosomal triglyceride transfer protein large subunit(Homo sapiens (Human))
Pfizer Inc
Curated by ChEMBL
Pfizer Inc
Curated by ChEMBL
Affinity DataIC50: 0.00200nMAssay Description:Inhibition of MTP in human HepG2 cells assessed as unbound drug level causing inhibition of apoB secretion after 40 hrs by ELISAMore data for this Ligand-Target Pair
TargetMicrosomal triglyceride transfer protein large subunit(Homo sapiens (Human))
Pfizer Inc
Curated by ChEMBL
Pfizer Inc
Curated by ChEMBL
Affinity DataIC50: 0.0100nMAssay Description:Inhibition of MTP in human HepG2 cells assessed as unbound drug level causing inhibition of apoB secretion after 40 hrs by ELISAMore data for this Ligand-Target Pair
TargetMicrosomal triglyceride transfer protein large subunit(Homo sapiens (Human))
Pfizer Inc
Curated by ChEMBL
Pfizer Inc
Curated by ChEMBL
Affinity DataIC50: 0.0110nMAssay Description:Inhibition of MTP in human HepG2 cells assessed as unbound drug level causing inhibition of apoB secretion after 40 hrs by ELISAMore data for this Ligand-Target Pair
TargetMicrosomal triglyceride transfer protein large subunit(Homo sapiens (Human))
Pfizer Inc
Curated by ChEMBL
Pfizer Inc
Curated by ChEMBL
Affinity DataIC50: 0.0210nMAssay Description:Inhibition of MTP in human HepG2 cells assessed as unbound drug level causing inhibition of apoB secretion after 40 hrs by ELISAMore data for this Ligand-Target Pair
TargetMicrosomal triglyceride transfer protein large subunit(Homo sapiens (Human))
Pfizer Inc
Curated by ChEMBL
Pfizer Inc
Curated by ChEMBL
Affinity DataIC50: 0.0250nMAssay Description:Inhibition of MTP in human HepG2 cells assessed as unbound drug level causing inhibition of apoB secretion after 40 hrs by ELISAMore data for this Ligand-Target Pair
TargetMicrosomal triglyceride transfer protein large subunit(Homo sapiens (Human))
Pfizer Inc
Curated by ChEMBL
Pfizer Inc
Curated by ChEMBL
Affinity DataIC50: 0.0580nMAssay Description:Inhibition of MTP in human HepG2 cells assessed as unbound drug level causing inhibition of apoB secretion after 40 hrs by ELISAMore data for this Ligand-Target Pair
TargetMicrosomal triglyceride transfer protein large subunit(Homo sapiens (Human))
Pfizer Inc
Curated by ChEMBL
Pfizer Inc
Curated by ChEMBL
Affinity DataIC50: 0.0660nMAssay Description:Inhibition of MTP in human HepG2 cells assessed as unbound drug level causing inhibition of apoB secretion after 40 hrs by ELISAMore data for this Ligand-Target Pair
TargetMicrosomal triglyceride transfer protein large subunit(Homo sapiens (Human))
Pfizer Inc
Curated by ChEMBL
Pfizer Inc
Curated by ChEMBL
Affinity DataIC50: 0.101nMAssay Description:Inhibition of MTP in human HepG2 cells assessed as unbound drug level causing inhibition of apoB secretion after 40 hrs by ELISAMore data for this Ligand-Target Pair
TargetMicrosomal triglyceride transfer protein large subunit(Homo sapiens (Human))
Pfizer Inc
Curated by ChEMBL
Pfizer Inc
Curated by ChEMBL
Affinity DataIC50: 0.105nMAssay Description:Inhibition of MTP in human HepG2 cells assessed as unbound drug level causing inhibition of apoB secretion after 40 hrs by ELISAMore data for this Ligand-Target Pair
TargetMicrosomal triglyceride transfer protein large subunit(Homo sapiens (Human))
Pfizer Inc
Curated by ChEMBL
Pfizer Inc
Curated by ChEMBL
Affinity DataIC50: 0.122nMAssay Description:Inhibition of MTP in human HepG2 cells assessed as unbound drug level causing inhibition of apoB secretion after 40 hrs by ELISAMore data for this Ligand-Target Pair
